Showing results (151-160 of 163) with videos related to
Sort By:
Pageof 17
Nature|July 20, 2010
Regulation of myeloid leukaemia by the cell-fate determinant MusashiTakahiro Ito, Hyog Young Kwon, Bryan Zimdahl, et al.Blood|May 31, 2013
Tyrosine kinase inhibitors impair B-cell immune responses in CML through off-target inhibition of kinases important for cell signalingHugues de Lavallade, Ahmad Khoder, Melanie Hart, et al.Blood|August 30, 2002
Bone marrow transplantation from HLA-identical siblings as treatment for myelodysplasiaJorge Sierra, Waleska S Pérez, Ciril Rozman, et al.Nature Genetics|September 2, 2008
A genome-wide association study identifies six susceptibility loci for chronic lymphocytic leukemiaMaria Chiara Di Bernardo, Dalemari Crowther-Swanepoel, Peter Broderick, et al.Nature Genetics|December 3, 2013
A genome-wide association study identifies multiple susceptibility loci for chronic lymphocytic leukemiaHelen E Speedy, Maria Chiara Di Bernardo, Georgina P Sava, et al.Haematologica|May 30, 2013
The BCR-ABLT315I mutation compromises survival in chronic phase chronic myelogenous leukemia patients resistant to tyrosine kinase inhibitors, in a matched pair analysisFranck E Nicolini, Amr R Ibrahim, Simona Soverini, et al.Blood|June 16, 2012
Common variation at 6p21.31 (BAK1) influences the risk of chronic lymphocytic leukemiaSusan L Slager, Christine F Skibola, Maria Chiara Di Bernardo, et al.Nature Genetics|January 12, 2010
Common variants at 2q37.3, 8q24.21, 15q21.3 and 16q24.1 influence chronic lymphocytic leukemia riskDalemari Crowther-Swanepoel, Peter Broderick, Maria Chiara Di Bernardo, et al.The New England Journal of Medicine|March 1, 2002
Hematologic and cytogenetic responses to imatinib mesylate in chronic myelogenous leukemiaHagop Kantarjian, Charles Sawyers, Andreas Hochhaus, et al.Blood|December 2, 2016
Consensus guidelines for the diagnosis and management of patients with classic hairy cell leukemiaMichael R Grever, Omar Abdel-Wahab, Leslie A Andritsos, et al.Pageof 17